• Organisation of Pharmaceutical Producers of India (OPPI) established in 1965, is a premier association of research based international and large pharmaceutical companies in India and is also a scientific and professional body. It caters to the needs of Research based Pharmaceutical Industry thereby creating and sustaining an environment conducive to innovation and growth, simultaneously, facilitating industry and stakeholders partnership through various advisory and consultative processes to achieve the Healthcare objectives of the Nation.

• OPPI Members Follow:

  • Good Manufacturing Practices (GMP)

  • International Code of Pharmaceutical Marketing Practices

  • OPPI’s position on Intellectual Property Rights (IPR)

• OPPI functions mainly on the following areas:
  
       1. Continuous dialogue with the stakeholders
       2. Actively engage in knowledge creation & knowledge sharing with value addition
       3. Engage in ‘Corporate Academia’ Interaction

• OPPI identifies itself with the country’s national healthcare objectives and encourages its members to make substantial contributions to social concerns and actively promotes Corporate Social Responsibility (CSR).

• OPPI is an active member of International Federation of Pharmaceutical Manufacturers Associations (IFPMA), Geneva.
  
  

To be an Active Partner with Government, Non-Governmental Organisations (NGOs) and other healthcare providers in improving the health and quality of life of our people through reduced morbidity and mortality by discovering, developing and making available safe, cost-effective and quality medicines. In particular, to play an important role in improving the access to medicines of people in rural areas and those living at or below the poverty line.

To build on India's existing strengths in manufacturing and Distribution and substantially enhance the beginnings made in R&D in order to become one of the leading players in the global pharmaceuticals market.

To develop a realization that the degree of success that the Industry attains in these areas will be a direct function of the emphasis given to the development of a sound system of Intellectual Property Rights, Biological Sciences Research (particularly genomics and proteomics), Clinical Research & Development and Innovative Process Chemistry.

To make India a global sourcing base of high quality pharmaceuticals to international consumers.

To be one of the major creators of intellectual capital and wealth for the economy.